Modifiable risk factors for developing otitis media with effusion in children under 12 years in high-income countries: a systematic review
- PMID: 39304206
- DOI: 10.1136/archdischild-2024-327454
Modifiable risk factors for developing otitis media with effusion in children under 12 years in high-income countries: a systematic review
Abstract
Objective: To systematically assess the modifiable risk factors for developing otitis media with effusion (OME) in children under 12 years.
Methods: We searched Embase, MEDLINE, INAHTA database, CENTRAL, CDSR and Epistemonikos for cohort studies with ≥40 children per arm/prognostic factor, published in English from 2000 to November 2022. We assessed risk of bias using the Quality in Prognosis Studies checklist, and overall evidence quality was assessed using Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology. Outcomes were analysed as risk ratio (RR), OR or Peto OR.
Results: Seven studies totalling 2 760 292 children were included. The evidence was very low quality. Fluid or pus discharge from ears (OR 2.1, 95% CI 1.01 to 4.35) and exposure to other children (RR 2.79, 95% CI 1.98 to 3.93) (OR 5.21, 95% CI 2.9 to 9.36) were strongly associated with development of OME. Coughs/colds ≥5 times (OR 1.91, 95% CI 1.22 to 2.99), breathing problems ≥5 times (RR 1.78, 95% CI 1.26 to 2.53) and ear infections (RR 1.95, 95% CI 1.39 to 2.72) in past year were associated with development of OME. Adenoid hypertrophy was strongly associated with development of fluctuating OME (recurrent OME) (OR 9.96, 95% CI 5.17 to 19.19). There was scare evidence for some potential modifiable risk factors, including breast feeding, household smoking, gastro-oesophageal reflux, dummy use and swimming.
Conclusions: Upper respiratory tract infection, ear infection, adenoid hypertrophy and exposure to other children could be the predictors for development of OME. Further observational studies are needed to investigate other potential modifiable risk factors.
Keywords: Audiology; Child Development; Child Health; Paediatrics.
© Author(s) (or their employer(s)) 2025. No commercial re-use. See rights and permissions. Published by BMJ Group.
Conflict of interest statement
Competing interests: A full list of interests for the whole committee for the 2023 NICE guideline on ‘Otitis media with effusion in under 12s’ (National Institute for Health and Care Excellence, 2023) is available at https://www.nice.org.uk/guidance/ng233/history. TMHB has been involved in assistive technology research and development (without financial gain) of a device, app and website (www.hearglueear.co.uk) to help children once they have glue ear. The authors declare no potential conflicts of interest associated with this article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous